🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to evaluate the efficacy and safety of TQB2102 com...
Status
Not Yet Recruiting
Location
Henan cancer hospital
Start Date
2025-09-01
Trial ID
NCT07136974
Treatments Being Tested
TQB2102 is an antibody-drug conjugate comprised of a humanised antibody aga...
Status
Completed
Location
Anhui Pronvincial Cancer Hospital
Start Date
2023-11-17
Trial ID
NCT06115902
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This study retrospectively analyzes the clinical data of HER2-low breast ca...
Status
Recruiting
Location
Sun yat-sen University Cancer
Start Date
2020-01-01
Trial ID
NCT06877416
Treatments Being Tested
This is a randomized, open, positive drug control, multi center phase III s...
Status
Recruiting
Location
The First Affiliated Hospital of Bengbu Medical University
Start Date
2025-09-15
Trial ID
NCT07043725
The study is a Phase III, randomized, multicenter, open-label study in HER2...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Bengbu Medical University
Start Date
2024-08
Trial ID
NCT06561607
Treatments Being Tested
TQB2102 is an antibody-drug conjugate comprised of a humanised antibody aga...
Status
Recruiting
Location
Cancer Hospital Chinise Academy of Medical Sciences
Start Date
2025-03-13
Trial ID
NCT06798207
Treatments Being Tested
This study aims to evaluate the efficacy and safety of TQB2102 for injectio...
Status
Recruiting
Location
Bozhou People's Hospital
Start Date
2024-11-14
Trial ID
NCT06452706
Treatments Being Tested
This study adopted a randomized, open-label, positive drug-controlled, mult...
Status
Recruiting
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2025-07-07
Trial ID
NCT07008976
Treatments Being Tested
To evaluate the efficacy and safety of neoadjuvant treatment with TQB2102 f...
Status
Active Not Recruiting
Location
Chongqing Cancer Hospital
Start Date
2024-02-05
Trial ID
NCT06198751
Treatments Being Tested